A Cure for Cancer? Israeli Scientists Say They Think They Found One
jpost.com
jpost.com
If your treatment doesn't involve weekly multi-thousand dollar doses for many years, then the pharmaceutical industry will shut it down as a risk to their profits
Perhaps they can corner the cancer market and still make a $trillion while lowering costs per patient too. Peptides are very cheap to produce.